SKI Market

A+| A| A-|

Indian Indices

Sensex

77,470.11 -238.41
( -0.31%)

Global Indices

Nasdaq

51,860.73 -306.69
(-0.59%)

Dow Jones

7,464.20 -14.49
(-0.19%)

Hang Seng

66,064.76 1,923.64
(3.00%)

Nikkei 225

10,542.79 -57.58
(-0.54%)

Forex

USD-INR

96.42 0.06
(0.07%)

EUR-INR

110.27 -0.10
(-0.09%)

GBP-INR

129.65 -0.46
(-0.35%)

JPY-INR

0.59 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

35.2

67.63

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

Sangam (India) consolidated net profit rises 898.78% in the December 2025 quarter

Jan 21,2026

Net profit of Sangam (India) rose 898.78% to Rs 24.47 crore in the quarter ended December 2025 as against Rs 2.45 crore during the previous quarter ended December 2024. Sales rose 2.74% to Rs 774.66 crore in the quarter ended December 2025 as against Rs 753.99 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	774.66	753.99	3
OPM %	10.89	8.49	-
PBDT	57.32	39.35	46
PBT	32.80	10.48	213
NP	24.47	2.45	899

77,470.11 -238.41 ( -0.31%)

51,860.73 -306.69 (-0.59%)

7,464.20 -14.49 (-0.19%)

66,064.76 1,923.64 (3.00%)

10,542.79 -57.58 (-0.54%)

96.42 0.06 (0.07%)

110.27 -0.10 (-0.09%)

129.65 -0.46 (-0.35%)

0.59 0.00 (-0.05%)